Member Info for TonyFawcett

Loads of volume buys, buyers dwarf sellers and MM’s short of stock , it’s a perfect scenario GLA

Re Rate due now, we are talking double digit SP soon, well done all long term holders for believing that Block will soon be a mid cap Oil & Gas Producer soon and the SP climbing substantially over the coming weeks and months.

RJ Bond.
Really enthusiastic first Post may I add Mr RJ Bond. I have the rights on talking *******s, not you !

While the major energy companies divest out of oil and gas production in favour of renewables could lessen the production of oil and increase the price . The move to electric cars, planes ,lorries is further away than people think and demand for oil and gas will be here for some time yet.

With the launch of more vaccines it’s becoming apparent that the length of immunity is still unknown, who and who has not had the vaccine. Are there any short or long term side effects ? We know that some have adverse reactions to the flu jab, and these people who have an allergic reaction to the flu jab will have the same reaction to a COVID 19 inoculation. This means that testing for purposes of work, attending sports events, travel , going to the theatre and cinema. Tests are going to be a major tool , accompanied with a health passport that will probably only last an limited amount of time will play a major a role of getting normality back into our live hand in hand with mass inoculation, bearing in mind it could take upto a year to inoculate the population starting with the old and vulnerable.

Intraday day RNS still possible or the yanks will save the day like yesterday.

Dr Al should’ve gone to Eton College , and things may have happened quicker for Avacta.

What is transpiring is that members of the Government have been giving preferential opportunities to their friends, this could have serious consequences for the current Johnson Administration, if as is seems that friends of some of the Cabinet and advisers have been given special treatment and escaped the usual scrutiny . Business Secretary Alok Sharma awkwardly dodged questions this morning on BBC Breakfast.

Profit takers gone, buyer’s returning.

Will we see 5p today ? There may be some profit taking but I think Bloe is back on a few peoples radar again. So I am hoping for a blue day at least.

Sagetrade,
Was Dr Als house a Persimmon House ? I hope so.

ODX can manage an update, the reported NDA is seemingly nothing but a smoke screen, I’m not asking for Avacta to wave a magic want neither was I thinking of selling my shares, I just think we as investors should be updated or at the very least tools why we haven’t had any updates as to progress. We are being kept in the dark , Dr Al told is in early summer that we were to expect a substantial newsflow unfortunately the opposite has been true. No mention of the Citiva partnership which appears to have gone to sleep , yes I am negative and frustrated and so are many more.

The mood on here is certainly one of frustration, we are even ridiculing our own tests or absence of them. I am as frustrated as everyone else and think we should demand an immediate update from Dr Al , I am tired of seemingly being led up the garden path while other competitors are overtaking us on sales with inferior testing devices. I am sure I am not the only person that feels that Avacta are missing the boat big style. It’s not just me that’s disappointed, it’s all the people I put into these that seem to ring me to tell how much the SP has gone down, never ring when the sp goes up. If their technology and science was so good why aren’t we being talked about. The NDA slant is starting to wear a bit thin with me.

Dispatches CH4 , the whole government testing job stinks, all backhanders, wheels within wheels and who you know.

Covid testing Documentary C4 now

I have no idea why Matt Han**** is still in the job, I dont have any confidence in him whatsoever.

Where do we see the SP at the end of the week and month end ? And year end. I think 5p wk, 7p mth, 12p y/e

We could double from here in a very short time.

It’s incredibly frustrating to be almost kept in the dark regarding our investment in Avacta, if not for the much talked about NDA you would almost think we were being misled . News can’t come quick enough for me.

Feb 19

Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that ModernaTX, Inc. (NASDAQ: MRNA) has exercised its option to enter into an exclusive licensing agreement with respect to certain Affimers against a potential therapeutic target that has been part of an ongoing research collaboration between the two companies.